BioCentury
ARTICLE | Company News

FDA approves expanded Xiaflex label

October 22, 2014 3:53 AM UTC

FDA approved an sBLA from Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) for Xiaflex collagenase clostridium to treat up to two Dupuytren's contracture joints in the same hand during a single treatment visit. The injectable form of collagenase previously was approved for one collagen cord.

Auxilium said 35-40% of Dupuytren's surgeries are performed on multiple joints. The stock was up $0.53 to $31.12 on Tuesday. ...